I-MAB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 EUR | -0.63% |
|
-1.26% | -5.99% |
| Jun. 06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
1b7c70f688924e3abd872f7.VjiZhWMAYmIYOX7b811C7sK58RFX2swk8239ZW8h-JU.PGf-9RQyMix8eA-4iRIA16iIxFATsfxIqRy7FRVM1a0zW9bNFjQXUlJ7Mw~1789ff82b69417d826997549664b5d6d
